Selection criteria for oxytocin stress test

Area of Science:

• Obstetrics and Gynecology
• Fetal Monitoring
• Maternal-Fetal Medicine

Background:

• Antenatal cardiotocography, including the non-stress test (NST), is a standard method for fetal surveillance.
• The oxytocin stress test (OST) is sometimes used to further evaluate fetal well-being.
• Determining the optimal patient population for OST is crucial for efficient clinical practice.

Purpose of the Study:

• To investigate the clinical utility of the oxytocin stress test (OST) in relation to the non-stress test (NST).
• To identify specific patient groups who would benefit most from undergoing an OST.

Main Methods:

• A retrospective analysis of 151 oxytocin stress tests (OSTs) performed on 112 patients selected from 1071 undergoing routine antenatal cardiotocography (non-stress test, NST).
• Patients were categorized into two groups: those with normal or suspect pathologic NST, and those with slight or severe pathologic NST.
• Test results were analyzed based on these patient classifications.

Main Results:

• In the group with normal or suspect pathologic NST (85 OSTs), only 2 tests were positive.
• In the group with slight or severe pathologic NST (66 OSTs), 22 tests were positive.
• The OST yielded minimal additional information when the preceding NST was normal.

Conclusions:

• The oxytocin stress test (OST) offers limited incremental value in cases where the non-stress test (NST) is normal.
• The OST should be reserved for patients with abnormal or pathologic non-stress test (NST) findings.
• This selective application of OST can optimize the use of fetal monitoring resources.